Search Results - "RECKER, F"

Shaping the future of obstetric/gynecological ultrasound training by Matschl, J., Gembruch, U., Strizek, B., Recker, F.

Get full text

Teledidactic Versus Hands-on Teaching of Abdominal, Thoracic, and Thyroid Ultrasound—The TELUS II Study by Höhne, E., Recker, F., Brossart, P., Schäfer, V. S.

“…Background The worldwide COVID-19 pandemic has initiated a change in medical education and the development of new teaching concepts has become inevitable to…”
Get full text

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data by Heijnsdijk, E A M, de Carvalho, T M, Auvinen, A, Zappa, M, Nelen, V, Kwiatkowski, M, Villers, A, Páez, A, Moss, S M, Tammela, T L J, Recker, F, Denis, L, Carlsson, S V, Wever, E M, Bangma, C H, Schröder, F H, Roobol, M J, Hugosson, J, de Koning, H J

“…The results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) trial showed a statistically significant 29% prostate cancer mortality…”
Get full text

Vesicoamniotic shunting for fetal megacystis in the first trimester with a Somatex® intrauterine shunt by Strizek, B., Gottschalk, I., Recker, F., Weber, E., Flöck, A., Gembruch, U., Geipel, A., Berg, C.

“…Purpose The objective was to evaluate the feasibility of vesicoamniotic shunting (VAS) in the first trimester with the Somatex ® intrauterine shunt and report…”
Get full text

Prevalence of joint, entheseal, tendon, and bursal findings in young, healthy individuals by musculoskeletal ultrasound by Schreiner, JK, Scheicht, D, Karakostas, P, Recker, F, Ziob, J, Behning, C, Preuss, P, Brossart, P, Schäfer, VS

“…The purpose of this study was to determine the prevalence of joint, enthesis, bursa, and tendon ultrasound findings in large and medium joints of young,…”
Get full text

Impact of COVID-19 on gynaecological patient care: results of patient’s survey with 327 patients by Recker, F., Dohmen, S., Egger, E. K., Stope, M. B., Dimitrova, D., Könsgen, D., Ritter, M., Sehouli, J., Bondio, M. Gadebusch, Mustea, A.

“…Purpose The pandemic SARS-CoV-2 poses new and unprecedented challenges for health care systems on a national and global level. Although the current situation…”
Get full text

Indication for active surveillance in the era of MRI-targeted biopsies by Wetterauer, C., Federer Gsponer, J.R., Leboutte, F., Mona, R., Ebbing, J., Rentsch, C.A., Manka, L., Seifert, H.H., Wyler, S., Recker, F., Kwiatkowski, M.

Get full text

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience by Recker, F, Kwiatkowski, M K, Huber, A, Stamm, B, Lehmann, K, Tscholl, R

“…Little is known about the incidence rate and clinical relevance of prostate cancer in a low prostate specific antigen (PSA) level. In a prospective PSA based…”
Get more information

Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland by Kwiatkowski, M., Huber, A., Stamm, B., Lehmann, K., Wernli, M., Häfeli, A., Recker, F.

“…OBJECTIVE To report the results from Switzerland's participation in the ERSPC from 1998; importantly, epidemiological data showed that Switzerland has one of…”
Get full text

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer by Hugosson, Jonas, Roobol, Monique J., Månsson, Marianne, Tammela, Teuvo L.J., Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Carlsson, Sigrid V., Talala, Kirsi M., Lilja, Hans, Denis, Louis J., Recker, Franz, Paez, Alvaro, Puliti, Donella, Villers, Arnauld, Rebillard, Xavier, Kilpeläinen, Tuomas P., Stenman, Ulf H., Godtman, Rebecka Arnsrud, Stinesen Kollberg, Karin, Moss, Sue M., Kujala, Paula, Taari, Kimmo, Huber, Andreas, van der Kwast, Theodorus, Heijnsdijk, Eveline A., Bangma, Chris, De Koning, Harry J., Schröder, Fritz H., Auvinen, Anssi

“…The European Randomized study of Screening for Prostate Cancer (ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening decreases…”
Get full text

A severe complication of retroperitoneoscopic nephrectomy by Sautter, T, Haueisen, H, Stierli, P, Kwiatkowski, M, Recker, F

Get more information

Laparoscopic dismembered pyeloplasty: preliminary report by Recker, F, Subotic, B, Goepel, M, Tscholl, R

“…As a reconstructive laparoscopic procedure, dismembered pyeloplasty was done in 5 patients: the laparoscopic procedure was completed in 4 and converted to an…”
Get more information

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma by Recker, Franz, Kwiatkowski, Maciej K., Piironen, Timo, Pettersson, Kim, Lümmen, Gerd, Wernli, Martin, Wiefelspütz, Johannes, Graber, Samuel F., Goepel, Mark, Huber, Andreas, Tscholl, Reto

“…BACKGROUND Human glandular kallikrein (hK2), the prostate specific antigen (PSA) close homologue, possesses approximately 80% structure identity with PSA. The…”
Get full text

Quantitative determination of urinary marker proteins: a model to detect intrarenal bioeffects after extracorporeal lithotripsy by Recker, F, Hofmann, W, Bex, A, Tscholl, R

“…To detect the source of relevant acute intrarenal side effects after extracorporeal piezoelectric lithotripsy and its impact on repeat treatment, urinary…”
Get more information

Decreasing screening efficacy with increasing age: Results from a population-based screening trial - Swiss ERSPC (Aarau) by Prause, L, Wyler, S, Möltgen, T, Huber, A, Grobholz, R, Manka, L, Recker, F, Kwiatkowski, M

Get full text

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer by Remmers, Sebastiaan, Bangma, Chris H., Godtman, Rebecka A., Carlsson, Sigrid V., Auvinen, Anssi, Tammela, Teuvo L.J., Denis, Louis J., Nelen, Vera, Villers, Arnauld, Rebillard, Xavier, Kwiatkowski, Maciej, Recker, Franz, Wyler, Stephen, Zappa, Marco, Puliti, Donella, Gorini, Giuseppe, Paez, Alvaro, Lujan, Marcos, Nieboer, Daan, Schröder, Fritz H., Roobol, Monique J.

“…A man’s baseline prostate-specific antigen level can guide decisions on the repeat screening interval, as demonstrated using 16-yr follow-up data from the…”
Get full text

U.S. Preventive Services Task Force Recommendation“ oder „Das Kind mit dem Bade ausschütten by Recker, F.

Get full text

PSA screening 2013: background and perspectives by Recker, F, Seiler, D, Seifert, B, Randazzo, M, Kwiatkowski, M

“…In the healthcare political discussions on treatment measures, the controversy over prostate-specific antigen (PSA) screening has taken a leading role in…”
Get full text

92 Swiss prostate-check: A population based risk-calculator for next generation prostate cancer screening by Kwiatkowski, M, Wyler, S.F, Prause, L, Möltgen, T, Huber, A, Grobholz, R, Manka, L, Seifert, B, Randazzo, M, Recker, F

Get full text

Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia by Recker, F, Kwiatkowski, M K, Pettersson, K, Piironen, T, Lümmen, G, Huber, A, Tscholl, R

“…To determine whether the serum levels of total prostate-specific antigen (t-PSA), free PSA (f-PSA) and PSA complexed to alpha 1-antichymotrypsin (PSA-ACT)…”
Get more information